Risk factors of progressive community-acquired pneumonia in hospitalized children: A prospective study

Journal of Microbiology, Immunology and Infection

Volumn 48, Issue 1, 2015, Pages 36-42

  Huang, Ching Ying ^a   Chang, Lung ^a   Liu, Ching Chuan ^c   Huang, Yhu Chering ^d   Chang, Luan Yin ^e   Huang, Yi Chuan ^d   Chiu, Nan Chang ^a,b   Lin, Hsiao Chuan ^f   Ho, Yu Huai ^g   Chi, Hsin ^a,b   Huang, Li Min ^e  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

^b NURSING AND MANAGEMENT COLLEGE   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^d CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^e NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^f CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^g BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

Author keywords

Children; Community acquired pneumonia; Progressive pneumonia; Risk factor

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; CEFOTAXIME; CEFTRIAXONE; CEFUROXIME; ERYTHROMYCIN; HEMOGLOBIN; PENICILLIN DERIVATIVE; ROXITHROMYCIN; TEICOPLANIN; VANCOMYCIN; ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; AGE; ANTIBIOTIC THERAPY; ARTICLE; CHILD; CHILDHOOD DISEASE; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; DETERIORATION; EMPYEMA; FEMALE; FOLLOW UP; HUMAN; INFANT; LENGTH OF STAY; LEUKOCYTE COUNT; LOBAR PNEUMONIA; MAJOR CLINICAL STUDY; MALE; MYCOPLASMA PNEUMONIAE; PEDIATRIC WARD; PLEURA EFFUSION; PNEUMONIA; PROSPECTIVE STUDY; RISK ASSESSMENT; STREPTOCOCCUS PNEUMONIAE; TACHYPNEA; COMMUNITY-ACQUIRED INFECTIONS; HOSPITALIZATION; PNEUMONIA, BACTERIAL; PRESCHOOL CHILD; RISK FACTOR; TAIWAN; TREATMENT OUTCOME; UNIVERSITY HOSPITAL;

ACADEMIC MEDICAL CENTERS; ADOLESCENT; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HOSPITALIZATION; HUMANS; INFANT; MALE; PNEUMONIA, BACTERIAL; PROSPECTIVE STUDIES; RISK FACTORS; TAIWAN; TREATMENT OUTCOME;

EID: 84921345379     PISSN: 16841182     EISSN: 19959133     Source Type: Journal    
DOI: 10.1016/j.jmii.2013.06.009     Document Type: Article

References (19)

1. Mulholland K., Hilton S., Adegbola R., Usen S., Oparaugo A., Omosigho C., et al. Randomised trial of Haemophilus influenzae type-b tetanus protein conjugate for prevention of pneumonia and meningitis in Gambian infants. Lancet 1997, 349:1191-1197.
2. Cutts F.T., Zaman S.M.A., Enwere G., Jaffar S., Levine O.S., Okoko J.B., et al. Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in the Gambia: randomised, double-blind, placebo-controlled trial. Lancet 2005, 365:1139-1146.
3. Wardlaw T., Salama P., Johansson E.W., Mason E. Pneumonia: the leading killer of children. Lancet 2006, 368:1048-1050.
4. Bradley J.S., Byington C.L., Shah S.S., Alverson B., Carter E.R., Harrison C., et al. The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin Infect Dis 2011, 53:e25-e76.
5. Anon Serious infections in young infants in developing countries- rationale for a multicenter study. The WHO Young Infants Study Group. Pediatr Infect Dis J 1999, 18(10 Suppl.):S4-S7.
6. Palafox M., Guiscarfe H., Reyes H. Diagnostic value of tachypnoea in pneumonia defined radiologically. Arch Dis Child 2000, 82:41-45.
7. Oppenheimer S.J. Iron and its relation to immunity and infectious disease. J Nutr 2001, 131:616-633.
8. Wexler I.D., Knoll S., Picard E., Villa Y., Shoseyov D., Engelhard D., et al. Clinical characteristics and outcome of complicated pneumococcal pneumonia in a pediatric population. Pediatr Pulmonol 2006, 41:726-734.
9. Prais D., Kuzmenko E., Amir J., Harel L. Association of hypoalbuminemia with the presence and size of pleural effusion in children with pneumonia. Pediatrics 2008, 121:e533-e538.
10. Cochran J.B., Panzarino V.M., Maes L.Y., Tecklenburg F.W. Pneumococcus-induced T-antigen activation in hemolytic uremic syndrome and anemia. Pediatr Nephrol 2004, 19:317-321.
11. Huang D.T., Chi H., Lee H.C., Chiu N.C., Huang F.Y. T-antigen activation for prediction of pneumococcus-induced hemolytic uremic syndrome and hemolytic anemia. Pediatr Infect Dis J 2006, 25:608-610.
12. Coats M.T., Murphy T., Paton J.C., Gray B., Briles D.E. Exposure of Thomsen-Friedenreich antigen in Streptococcus pneumoniae infection is dependent on pneumococcal neuraminidase A. Microb Pathog 2011, 50:343-349.
13. Devitt M. PIDS and IDSA issue management guidelines for community-acquired pneumonia in infants and young children. Am Fam Physician 2012, 86:196-202.
14. Tan T.Q., Mason E.O., Wald E.R., Barson W.J., Schutze G.E., Bradley J.S., et al. Clinical characteristics of children with complicated pneumonia caused by Streptococcus pneumoniae. Pediatrics 2002, 110:1-6.
15. Francois P., Desrumaux A., Cans C., Pin I., Pavese P., Labarere J. Prevalence and risk factors of suppurative complications in children with pneumonia. Acta Paediatr 2010, 99:861-866.
16. Byington C.L., Spencer L.Y., Johnson T.A., Pavia A.T., Allen D., Mason E.O., et al. An epidemiological investigation of a sustained high rate of pediatric parapneumonic empyema: risk factors and microbiologic associations. Clin Infect Dis 2002, 34:434-440.
17. Kunyoshi V., Cataneo D.C., Cataneo A.J. Complicated pneumonias with empyema and/or pneumatocele in children. Pediatr Surg Int 2006, 22:186-190.
18. Michelow I.C., Olsen K., Lozano J., Rollins N.K., Duffy L.B., Ziegler T., et al. Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children. Pediatrics 2004, 113:701-707.
19. Lee P.I., Chiu C.H., Chen P.Y., Lee C.Y., Lin T.Y. Guidelines for the management of community-acquired pneumonia in children. Acta Paediatr Taiwan 2007, 48:167-180.